Chemotherapy in metastatic gastric cancer: population-based perceptions and practice patterns of medical oncologists.
Although randomised trials in metastatic gastric cancer have shown a survival benefit from chemotherapy, a significant proportion of medical oncologists do not believe that it prolongs survival or improves quality of life, including those who routinely treat metastatic gastric cancer. There was wide variation in what was considered to be 'standard therapy' and a statistically significant difference between what medical oncologists consider 'standard therapy' and what they use in every day practice.
Wood
L A
LA
Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Room 461, Bethune Building, 1278 Tower Road Halifax, Nova Scotia, Canada B3H 2Y9. lori.wood@cdha.nshealth.ca
Fields
A L A
AL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002170:Canada; D019538:Health Care Surveys; D006801:Humans; D008495:Medical Oncology / Q000706:statistics & numerical data; D009362:Neoplasm Metastasis; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011379:Prognosis; D011788:Quality of Life; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013534:Survival